Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to alter the gastric acid pocket in GERD
2009-013080-19Phase 4Active
- Sponsor
- AMC Health
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of azithromycin in gastroesophageal reflux disease (GERD), sponsored by AMC Health. Primary endpoint: acid reflux episodes. Started Mar 2010; status: active.
02
Drugs
azithromycin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2009-013080-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013080-19.